Skip to main content

Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

Accelerating peptide
API development

On demand Webinar will be available soon.

Peptide-based drugs are an increasingly important segment of the pharmaceutical industry, with a projected $40 billion each year. Growing therapeutic potency and target selectivity have helped fuel the growth of peptide-based treatments, especially in oncology and metabolic diseases. As a result, peptide-based drugs dominate the pharmaceutical industry; hundreds of peptide drugs are currently on the market, which amounts to 10% of all pharmaceutically marketed drugs, expecting that this number will grow.

A crucial component of helping formulator companies succeed is providing quality products, which plays a pivotal role in developing peptides. We can accomplish this by supervising the processes like peptide synthesis, purification, characterization techniques, product isolation, packing, transportation, and ensuring all manufacturing facilities operate efficiently and follow the latest quality, safety, regulatory, and productivity standards.

In this webinar, you will learn about our peptide capabilities, including – Research & development, quality control, synthesis, purification, complex characterization techniques, cGMP manufacturing facilities, and regulatory prerequisites accompanied by live case studies.



Synthesis of Peptides – Technology used in peptide development


Peptide design strategy including sequence design, modification selection, and purity choice


State-of-the-art complex characterization techniques


Dr. Rajeev Rehani Budhdev

Executive Vice President & Head
API R&D at Dr. Reddy’s Laboratories Limited, Hyderabad

Rajeev is currently working as Executive Vice President & Head – API R&D at Dr. Reddy’s Laboratories Limited, Hyderabad. He holds a Masters and a Ph.D. degree in Organic Chemistry from Maharaja Sayajirao (M.S.) University of Baroda. He brings with him over 30 years of experience in the areas of academic research at M.S.University, followed by Process Chemistry of generic APIs at Sun Pharma’s R&D centre at Baroda, leading to numerous DMF/ANDA filings for a gamut of molecules of varying complexities, including Peptides. Rajeev is very passionate about R&D collaboration cutting across cross-functional domains, both within and outside the company, including external subject matter experts. He also has a number of patent publications to his credit and has delivered talks on emerging frontiers in Pharma Science and Technology.

Read More


Meet our API experts at the world’s
most expansive pharma platform

Join us at CPhI NA 2022!

17th-19th May, 2022 | PCC, PHL
Schedule a meeting